NCT02685748View on ClinicalTrials.gov

Aspirin in Young Psychotic Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 20, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
PsychosisAcute PsychosisSchizophrenia
Interventions
DRUG

Aspirin

1000 mg pd in two doses

DRUG

Placebo

two pills twice a day (instead of aspirin and pantoprazole)

DRUG

Pantoprazole

Pantoprazole 40 mg/pd in two doses, for gastric protection

Trial Locations (1)

11000

Clinic for psychiatric disorders Dr Laza Lazarevic, Belgrade

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Clinic for Psychiatric Disorders, Dr Laza Lazarevic

OTHER

NCT02685748 - Aspirin in Young Psychotic Patients | Biotech Hunter | Biotech Hunter